Lv2
140 积分 2023-12-06 加入
Correction to: “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline”
4小时前
求助中
Fifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
1个月前
已完结
How should rheumatologists manage glucocorticoid-induced hyperglycemia?
1个月前
已完结
Optimizing the Treatment of Steroid-Induced Hyperglycemia
1个月前
已完结
Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves’ orbitopathy: a systematic review and meta-analysis
1个月前
已完结
Long-term Cardiovascular, Renal, and Safety Outcomes of Teprotumumab versus Systemic Glucocorticoids in Thyroid Eye Disease: A Target Trial Emulation
1个月前
已完结
T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation
1个月前
已完结
Factors Associated with Response to Intravenous Glucocorticoids in Active Moderate-to-Severe Thyroid Eye Disease
2个月前
已完结
Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy
2个月前
已完结
Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia
2个月前
已完结
皖公网安备34019202002308
